Article -> Article Details

A report was recently published by Market Research Future (MRFR) assessing the dynamics in the global facial injectors market over the forecast period of 2018-2023. The facial injectors market is set to march on the growth trajectory at a CAGR of 11.12%, garnering a revenue valuation of USD 14571.47 million by the end of the forecast period. Various attributable factors to the growth of the facial injectors market share are studied in the MRFR report.

Booming of the entertainment industry and increased popularity of celebrity culture is affecting the lifestyle choices of the urban population and elevating bars of beauty standard measurements. Proliferating research and development for advanced aesthetic injectors, along with a growing demand for anti-aging and other beauty treatments in many emerging countries are attributed to the mounting growth of the facial injectors market over the assessment period.

However, some factors are also expected to refrain growth in the global facial injectors market. Side-effects caused due to the materials used as injectors, complications arising post surgeries, and the presence of the black market for facial injectors are likely to hinder market growth for facial injectors through the forecast period.

Get Sample Copy of Report @ https://www.marketresearchfuture.com/sample_request/6898 

Incorporation of advanced technologies in the healthcare sector has contributed heavily to the improved provision of procedures in cosmetic surgery and facial aesthetic treatment. Ascension in the preference towards minimally invasive treatments, coupled with the rising popularity of facial aesthetic treatments is estimated to fuel demand for facial injectors, driving the facial injectors market.

Key Players

 Some of the significant players profiled by MRFR that are operating in the global facial injectors market are SciVision Biotech Inc, Ipsen Pharma. Merck KGaA, Sanofi, Revance Therapeutics Inc., Sinclair Pharma, Galderma S.A., Suneva Medical Inc., Merz Pharma, Valeant Pharmaceuticals, Allergan, and Integra LifeSciences Corporation.

Market Segmentation

The global facial injectors market report also has analysis carried out on a segmental basis. This includes the different types of facial injectors, several applications of these facial injectors, and end-users.

• By Types of facial injectors studied in the report include types of anti-aging/anti-wrinkle injections and dermal fillers/injectable implants. Types of dermal fillers implants include synthetic fillers, collagen fillers, and hyaluronic acid. The dermal fillers/injectable implants are anticipated to be the most popular type of facial injectors and are likely to witness the highest rate of adoption over the forecast period. This segment is anticipated to exhibit an 11.61% CAGR between 2018-2023. Hyaluronic acid is the most preferred filler facial injection and is likely to maintain the status over the forthcoming years, expanding at 11.69% CAGR.
• By Applications of facial injectors are face-lift and facial line correction treatment and lip treatment. The highest use of facial injector is done for facial line correction and is likely to generate the highest revenue at 10.43% CAGR by 2023. On the other hand, the use of facial injectors for facelifts is expected to witness the fastest growing demand over the forecast period.
• By End-users of facial injectors include hospitals, and dermatology clinics & cosmetic centers. Among these, the dermatology clinics & cosmetic centers are estimated to demand highest facial injectors and are estimated to contribute a revenue valuation of USD 6061.35 million to the facial injectors market. The consumption of facial injectors in dermatology clinics & cosmetic center is expected to expand at 10.78% CAGR during the assessment period.

Detailed Regional Analysis

The global facial injectors market is regionally segmented into the Americas, Europe, Asia Pacific, and the Middle East & Africa. The Americas are expected to fetch the largest share in the global facial injectors market during the review period. By 2023, the Americas are anticipated to garner a revenue valuation of USD 6339.94, reflecting lucrative growth in the global facial injectors market.

Get Access Full Report @ https://www.marketresearchfuture.com/reports/facial-injectors-market-6898 

Such market dominion can be accredited to the rising popularity of the facial aesthetic treatment, availability of high-quality treatment, and increasing disposable income of consumers in the region. Asia Pacific is expected to upscale at the fastest rate of 12.02% CAGR over the forecast period. This can be owed to the boosting of the entertainment industry and the influence of the same on the population.

Industry Update

May 2019: Evolus recently announced their launch of Jeuveau in the U.S. cosmetic procedures market. Jeuveau is a neurotoxin used to treat wrinkles which received their U.S. FDA approval in February 2019.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited), 

99 Hudson Street,5Th Floor, New York, New York 10013, 

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com